ODDB.org: Open Drug Database

Mepha Pharma AG - Mirtazapin-Mepha 30 mg, Filmtabletten

Swissmedic Registration	61342	Sequence	02
Product name	Mirtazapin-Mepha 30 mg	Description	Filmtabletten
ATC-Classification	N06AX11	ATC-Description	Mirtazapine
Introduction of Sequence	12.04.2011

Composition

Filmtablette: mirtazapinum 30 mg, lactosum monohydricum 126.9 mg, cellulosi pulvis, carboxymethylamylum natricum A corresp. natrium 0.38 mg, amylum pregelificatum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, talcum, macrogolum 6000, E 171, E 172 (flavum), E 172 (rubrum) pro compresso obducto.

Packungsbestandteile

Galenic Form

Filmtablette

Active Agent	Dose	additional_information
Mirtazapine	30 mg	Filmtablette

BAG: Active Agent	Dose
Mirtazapine	30 mg

Inactive agents	Dose	additional_information
(Flavum)
(Rubrum) pro Compresso Obducto
Amylum Pregelificatum
Carboxymethylamylum Natricum A
Cellulosi Pulvis
E 171		color.
E 172		color.
Hypromellosum		Überzug
Lactose Monohydrate	126.9 mg
Macrogol	6000
Magnesii Stearas
Silica Colloidalis Anhydrica
Talcum

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
001	10 Tablet(s)	6.65	16.45	B	SL	No
002	30 Tablet(s)	17.50	35.45	B	SL	No
003	100 Tablet(s)	54.80	75.95	B	SL	No

2025	©ywesee GmbH